This is the old version of SRDR. The next, SRDRplus is available! Registration of your SRDRPlus account is free and approval is automatic. Click Here to register an SRDRPlus account.

Advanced Search

Project: Cervical Ripening in the Outpatient Setting

Public Report Complete



Project Summary

Title and Description


Key Questions


Associated Extraction Forms

Title Created by Key Questions Addressed Form Notes
Extraction Form Erica Hart 1, 2, 3, 4


Associated Studies (each link opens a new tab)

Title Author Year
A prospective study of induction of labor with prostaglandin vaginal gel: ambulatory versus in-patient administration. Awartani KA., Turnell RW., Olatunbosun OA. 1999
Vaginal misoprostol for cervical ripening at term: comparison of outpatient vs. inpatient administration. Chang DW., Velazquez MD., Colyer M., Klaus P., Mallipeddi SK., Rayburn WF. 2005
Observational Study of Neonatal Safety for Outpatient Labour Induction Priming with Dinoprostone Vaginal Insert. Cundiff GW., Simpson ML., Koenig N., Lee T. 2017
A cost-minimization analysis of intracervical prostaglandin E2 for cervical ripening in an outpatient versus inpatient setting. Farmer KC., Schwartz WJ., Rayburn WF., Turnbull G. -- Not Found --
Dinoprostone vaginal insert for labour induction: a comparison of outpatient and inpatient settings. Salvador SC., Lynn Simpson M., Cundiff GW. 2009
Home cervical ripening with dinoprostone gel in nulliparous women with singleton pregnancies. Stock SJ., Taylor R., Mairs R., Azaghdani A., Hor K., Smith I., Dundas K., Kissack C., Norman JE., Denison F. 2014
A randomized controlled trial of outpatient versus inpatient labour induction with vaginal controlled-release prostaglandin-E2: effectiveness and satisfaction. Biem SR., Turnell RW., Olatunbosun O., Tauh M., Biem HJ. 2003
A randomised controlled trial of outpatient compared with inpatient cervical ripening with prostaglandin E₂ (OPRA study). Wilkinson C., Bryce R., Adelson P., Turnbull D. 2015
Induction of labour using prostaglandin E Beckmann M., Gibbons K., Flenady V., Kumar S. 2020
Outpatient Foley catheter versus inpatient prostaglandin E2 gel for induction of labour: a randomised trial. Henry A., Madan A., Reid R., Tracy SK., Austin K., Welsh A., Challis D. 2013
Foley catheter induction of labor as an outpatient procedure. Kruit H., Heikinheimo O., Ulander VM., Aitokallio-Tallberg A., Nupponen I., Paavonen J., Rahkonen L. 2016
Outpatient Foley Catheter for Induction of Labor in Parous Women: A Randomized Controlled Trial. Kuper SG., Jauk VC., George DM., Edwards RK., Szychowski JM., Mazzoni SE., Wang MJ., Files P., Tita AT., Subramaniam A., Harper LM. 2018
Effectiveness and infectious morbidity of outpatient cervical ripening with a Foley catheter. McKenna DS., Duke JM. 2004
Outpatient versus inpatient cervix priming with Foley catheter: A randomized trial. Policiano C., Pimenta M., Martins D., Clode N. 2017
Transcervical Foley catheter for preinduction cervical ripening in an outpatient versus inpatient setting. Sciscione AC., Muench M., Pollock M., Jenkins TM., Tildon-Burton J., Colmorgen GH. 2001
Ambulatory cervical ripening in term pregnancy. Upadhyaya NB., Childs KD., Neiger R., Caudle MR. 1999
A comparison of inpatient with outpatient balloon catheter cervical ripening: a pilot randomized controlled trial. Wilkinson C., Adelson P., Turnbull D. 2015
Retrospective Comparison of PGE Blair R., Harvey MA., Pudwell J., Bougie O. 2020
Intracervical prostaglandin in postdate pregnancy. A randomized trial. Buttino LT., Garite TJ. 1990
Outpatient management of the uncomplicated postdate pregnancy with intravaginal prostaglandin E2 gel and membrane stripping. Doany W., McCarty J. -- Not Found --
Outpatient oral misoprostol for prolonged pregnancies: a pilot investigation. Gaffaney CA., Saul LL., Rumney PJ., Morrison EH., Thomas S., Nageotte MP., Wing DA. 2009
A comparison of oral and intracervical prostaglandin E2 for ripening of the unfavourable cervix prior to induction of labour. Herabutya Y., O-Prasertsawat P. 1988
Vaginally administered misoprostol for outpatient cervical ripening in pregnancies complicated by diabetes mellitus. Incerpi MH., Fassett MJ., Kjos SL., Tran SH., Wing DA. 2001
Use of misoprostol on an outpatient basis for postdate pregnancy. Kipikasa JH., Adair CD., Williamson J., Breen JM., Medford LK., Sanchez-Ramos L. 2005
Outpatient cervical ripening with prostaglandin E2 and estradiol. Larmon JE., Magann EF., Dickerson GA., Morrison JC. 2002
Antepartum cervical ripening: applying prostaglandin E2 gel in conjunction with scheduled nonstress tests in postdate pregnancies. Lien JM., Morgan MA., Garite TJ., Kennedy KA., Sassoon DA., Freeman RK. 1998
Membrane sweeping versus dinoprostone vaginal insert in the management of pregnancies beyond 41 weeks with an unfavorable cervix. Magann EF., Chauhan SP., McNamara MF., Bass JD., Estes CM., Morrison JC. 1999
Management of pregnancies beyond forty-one weeks' gestation with an unfavorable cervix. Magann EF., Chauhan SP., Nevils BG., McNamara MF., Kinsella MJ., Morrison JC. 1998
Foley catheter silicone versus latex for term outpatient induction of labour: A randomised trial. McGee TM., Gidaszewski B., Khajehei M., Tse T., Gibbs E. 2019
Prostaglandin E2 cervical ripening without subsequent induction of labor. McKenna DS., Costa SW., Samuels P. 1999
Misoprostol outpatient cervical ripening without subsequent induction of labor: a randomized trial. McKenna DS., Ester JB., Proffitt M., Waddell KR. 2004
Outpatient misoprostol compared with dinoprostone gel for preinduction cervical ripening: a randomized controlled trial. Meyer M., Pflum J., Howard D. 2005
Outpatient misoprostol cervical ripening without subsequent induction of labor to prevent post-term pregnancy. Oboro VO., Tabowei TO. 2005
Randomised trial of outpatient induction of labor with vaginal PGE2 at 40-41 weeks of gestation versus expectant management. Ohel G., Rahav D., Rothbart H., Ruach M. 1996
Randomized double-blind placebo controlled study of preinduction cervical priming with 25 µg of misoprostol in the outpatient setting to prevent formal induction of labour. PonMalar J., Benjamin SJ., Abraham A., Rathore S., Jeyaseelan V., Mathews JE. 2017
Weekly administration of prostaglandin E2 gel compared with expectant management in women with previous cesareans. Prepidil Gel Study Group. Rayburn WF., Gittens LN., Lucas MJ., Gall SA., Martin ME. 1999
Patient-administered outpatient intravaginal prostaglandin E2 suppositories in post-date pregnancies: a double-blind, randomized, placebo-controlled study. Sawai SK., O'Brien WF., Mastrogiannis DS., Krammer J., Mastry MG., Porter GW. 1994
Sequential outpatient application of intravaginal prostaglandin E2 gel in the management of postdates pregnancies. Sawai SK., Williams MC., O'Brien WF., Angel JL., Mastrogiannis DS., Johnson L. 1991
Double-blind comparison of 2.5 and 5.0 mg of prostaglandin E2 gel for preinduction cervical ripening. Smith CV., Miller A., Livezey GT. 1996
Outpatient cervical ripening with intravaginal misoprostol. Stitely ML., Browning J., Fowler M., Gendron RT., Gherman RB. 2000




Creative Commons LicenseThis graphic notice indicates that you are leaving this Federal Government Web site and entering a non-Federal Web site. Creative Commons  
The data contained in this project are distributed under the terms of the Creative Commons Attribution-NonCommerical license, which permits the use, dissemination, and reproduction in any medium, provided the original work is properly cited, and that the use is non-commercial and otherwise in compliance with the license. See: https://creativecommons.org/licenses/by-nc/3.0/